欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3104/003
药品名称Mitomycin 20 mg, Powder for Solution for Injection
活性成分
    • mitomycin 2.0 mg
剂型Powder for solution for injection
上市许可持有人Accord Healthcare BV Winthotiaan 200, PO Box 85183, 3508 AD Utrecht, The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Mitomycine Accord 20 mg, poeder voor oplossing voor injectie / infusie of intravesicaal gebruik
互认成员国 - 产品名称
    • Iceland (IS)
    • Estonia (EE)
    • Malta (MT)
      Mitomycin 2 mg Powder for solution for Injection/Infusion or Intravesical use
    • Finland (FI)
    • Germany (DE)
      Mitomycin Accord 2 mg Pulver zur Herstellung einer Injektionslösung
    • Belgium (BE)
      Mitomycin Accord 2 mg Poeder voor oplossing voor injectie / infusie of intravesicaal gebruik
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Italy (IT)
    • Spain (ES)
    • Portugal (PT)
    • Poland (PL)
      Mitomycin Accord
    • Bulgaria (BG)
      Mitomycin Acoord
    • Cyprus (CY)
      MITOMYCIN PWD FOR SOL FOR INJ
    • Czechia (CZ)
      MITOMYCIN ACCORD 2 MG PRÁŠEK PRO INJEKČNÍ/INFUZNÍ NEBO INTRAVEZIKÁLNÍ ROZTOK
    • Slovenia (SI)
许可日期2015/12/15
最近更新日期2024/04/02
药物ATC编码
    • L01DC03 mitomycin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase